A Study to Estimate the Effect of AZD5718 on the Pharmacokinetics (What Does the Body Does to the Drug) of Rosuvastatin to Measure the Relative Bioavailability (the Extent to Which a Drug or Other Substance Becomes Available to the Body) of AZD5718 Oral Suspension vs AZD5718 Immediate Release Tablet

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 20, 2016

Primary Completion Date

March 1, 2017

Study Completion Date

March 1, 2017

Conditions

High Risk Coronary Artery Disease

Interventions

DRUG

AZD5718 IR tablet

DRUG

AZD5718 oral suspension

DRUG

Rosuvastatin tablet

Trial Locations (1)

Research Site, London